We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.28B
AUM Growth
+$153M
Cap. Flow
+$142M
Cap. Flow %
11.06%
Top 10 Hldgs %
36.07%
Holding
204
New
47
Increased
62
Reduced
46
Closed
45

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26.2M
2
K
Kellanova
K
+$13.9M
3
CSTM icon
Constellium
CSTM
+$13.5M
4
PCG icon
PG&E
PCG
+$12.9M
5
CMC icon
Commercial Metals
CMC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 13.98%
3 Utilities 11.09%
4 Consumer Staples 8.76%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
101
Alphabet (Google) Class A
GOOGL
$4.36T
$3.83M 0.3%
21,000
-10,000
-32% -$1.69M
SHW icon
102
Sherwin-Williams
SHW
$82.7B
$3.82M 0.3%
12,800
+2,343
+22% +$725K
WCC
103
WESCO International
WCC
$16.7B
$3.76M 0.29%
23,703
-14,871
-39% -$2.53M
GPN icon
104
Global Payments
GPN
$23B
$3.73M 0.29%
+38,566
New +$4.25M
AVGO icon
105
Broadcom
AVGO
$1.85T
$3.53M 0.27%
22,000
-71,730
-77% -$10.1M
AMAT icon
106
Applied Materials
AMAT
$403B
$3.49M 0.27%
14,800
-2,400
-14% -$515K
CSTM icon
107
Constellium
CSTM
$3.76B
$3.46M 0.27%
183,410
-647,036
-78% -$13.5M
IT icon
108
Gartner
IT
$10.1B
$3.35M 0.26%
+7,453
New +$3.32M
GPRE icon
109
Green Plains
GPRE
$1.18B
$3.33M 0.26%
210,000
+30,540
+17% +$588K
DYN icon
110
Dyne Therapeutics
DYN
$4.7B
$3.26M 0.25%
92,390
+17,390
+23% +$505K
BL icon
111
BlackLine
BL
$1.84B
$3.25M 0.25%
+67,082
New +$3.68M
ALE
112
DELISTED
Allete
ALE
$3.22M 0.25%
+51,711
New +$3.18M
CLDX icon
113
Celldex Therapeutics
CLDX
$2.99B
$3.16M 0.25%
85,351
+16,062
+23% +$606K
CME icon
114
CME Group
CME
$96.3B
$3.05M 0.24%
15,506
-3,288
-17% -$679K
SNDX icon
115
Syndax Pharmaceuticals
SNDX
$1.69B
$2.94M 0.23%
143,280
+39,570
+38% +$828K
AES icon
116
AES
AES
$10.5B
$2.92M 0.23%
165,955
-9,313
-5% -$177K
MA icon
117
Mastercard
MA
$506B
$2.79M 0.22%
+6,332
New +$2.88M
DELL icon
118
Dell
DELL
$262B
$2.76M 0.21%
+20,000
New +$2.68M
COGT icon
119
Cogent Biosciences
COGT
$6.65B
$2.75M 0.21%
326,070
+11,070
+4% +$84K
CEG icon
120
Constellation Energy
CEG
$93.8B
$2.61M 0.2%
13,018
+8,118
+166% +$1.66M
SMAR
121
DELISTED
Smartsheet Inc.
SMAR
$2.61M 0.2%
59,114
-96,196
-62% -$3.83M
KO icon
122
Coca-Cola
KO
$377B
$2.55M 0.2%
+40,004
New +$2.48M
KEX icon
123
Kirby Corp
KEX
$7.01B
$2.52M 0.2%
21,024
-47,176
-69% -$5.27M
MNDY icon
124
monday.com
MNDY
$3.68B
$2.51M 0.2%
+10,418
New +$2.2M
VERA icon
125
Vera Therapeutics
VERA
$2.3B
$2.3M 0.18%
63,550
+11,958
+23% +$474K

Similar funds

Crestline Management's Q2 2024 Portfolio in Review

As of Q2 2024, Crestline Management held 204 positions worth $1.28B, up 14% from $1.13B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Crestline Management deployed $142M of net new capital in Q2 2024, opening 47 new positions and adding to 62 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 335,000 shares worth $183M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Constellium, an estimated $13.5M trimmed.

  • Crestline Management's largest Q2 2024 buy was iShares Core S&P 500 ETF: 335,000 shares worth $183M.
  • Crestline Management added most to Apple in Q2 2024, an estimated $18.1M increase.
  • Crestline Management's biggest Q2 2024 reduction was Constellium, cutting an estimated $13.5M.
  • Crestline Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2024, selling an estimated $26.2M.
  • Crestline Management's ten largest holdings make up 36% of its $1.28B portfolio in Q2 2024.
  • Crestline Management opened 47 new positions and closed 45 in Q2 2024.
  • Crestline Management's portfolio value rose 14% quarter-over-quarter to $1.28B.

Based on Crestline Management's 13F filing for Q2 2024, filed 14 Aug 2024.